Home » Tenders » Asia » Japan » AEculizumab (Genetical Recombination) 300mg, 30mL/1vial 399vials, Infliximab... Tender

AEculizumab (Genetical Recombination) 300mg, 30mL/1vial 399vials, Infliximab (Genetical... Tender

NATIONAL UNIVERSITY CORPORATION has floated a tender for AEculizumab (Genetical Recombination) 300mg, 30mL/1vial 399vials, Infliximab (Genetical Recombination) 100mg1vial 2, 665vials, Nusinersen Sodium 12mg, 5mL1vial 55vials. The project location is Japan and the tender is closing on 01 Apr 2019. The tender notice number is , while the TOT Ref Number is 29991775. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Japan

Summary : AEculizumab (Genetical Recombination) 300mg, 30mL/1vial 399vials, Infliximab (Genetical Recombination) 100mg1vial 2, 665vials, Nusinersen Sodium 12mg, 5mL1vial 55vials

Deadline : 01 Apr 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 29991775

Document Ref. No. :

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL UNIVERSITY CORPORATION
Yoshida Yasushi, Contract Affairs Section, Financial Management Division, Kobe University Hospital, 7-5-1 Kusunoki-cho Chuo-ku Kobe-shi 650-0017 Japan, TEL 078-382-5125
Japan

Tender Details

A?Eculizumab (Genetical Recombination) 300mg, 30mL/1vial 399vials, ??Infliximab (Genetical Recombination) 100mg?1vial 2, 665vials, ??Nusinersen Sodium 12mg, 5mL?1vial 55vials

Classification :
0004 Medical & Pharmaceutical Products

Summay of Notice :
? Official in charge of disbursement of the procuring entity : Kato Ken, Executive Vice President In Charge of Finance

? Classification of the products to be procured : 4

? Nature and quantity of the products to be purchased :

A Eculizumab (Genetical Recombination) 300mg, 30mL/1vial 399vials

B Infliximab (Genetical Recombination) 100mg/1vial 2, 665vials

C Nusinersen Sodium 12mg, 5mL/1vial 55vials

? Delivery period : From 1 April, 2019 through 31 March, 2020

? Delivery place : Kobe University Hospital

? Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

A not come under Article 3 and 4 of the Regulation concerning the Contract for Kobe University Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,

B have the Grade A or Grade B qualification during fiscal 2019 in the Kinki area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by Kobe University,

C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,

D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by The Obligating Officer,

E not be currently under a suspension of business order as instructed by Executive Vice President In Charge of Finance.

? Time limit of tender : 17 : 00 13 March, 2019

? Contact point for the notice : Yoshida Yasushi, Contract Affairs Section, Financial Management Division, Kobe University Hospital, 7-5-1 Kusunoki-cho Chuo-ku Kobe-shi 650-0017 Japan, TEL 078-382-5125